Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
9m
GSK says RSV vaccine protects against disease over three seasons
Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and ...
49m
Why Pfizer will find it hard to appease its activist investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
North Dakota wildfires
Kemp suspends GA mayor
Milton becomes Category 5
Medical copter crash kills 3
Sex abuse case dismissed
Human life expectancy study
Harris on '60 Minutes'
Tickets to climb to $5
Ranger dies during rescue
Vanderbilt, Arkansas fined
US overdose deaths drop
Grammy-winning singer dies
States sue TikTok
NC voting rule changes
Richest female musician
To replace lead water pipes
Intel defensive briefings rise
King named grand marshal
Win Nobel Prize in physics
SCOTUS denies appeal
Hamas backers sanctioned
Liquidation plan approved
Ordered to open app store
US antitrust case advances
Israel expands offensive
Athlete payments approval
Targeted by a cyberattack
Hera mission launched
Settles latest civil lawsuit
Related topics
GSK
Pfizer
RSV
Sanofi
United States
Feedback